{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:03:50Z","timestamp":1789664630582,"version":"4.0.1"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T00:00:00Z","timestamp":1177372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Fabry disease (FD) is an X\u2010linked disorder of glycosphingolipid catabolism that results from a deficiency of the lysosomal enzyme \u03b1\u2010galactosidase A. This defect leads to the accumulation of its substrates, mainly globotriaosylceramide, in lysosomes of cells of different tissues. Different studies have shown the involvement of immunopathologies in different sphingolipidoses. The coexistence of FD and immune disorders such as systemic lupus erythematosus, rheumatoid arthritis and IgA nephropathy, has been described in the literature. The aim of this study was to evaluate the prevalence of a group of autoantibodies in a series of Argentine FD patients. Autoantibodies against extractable nuclear antigens (ENAs), double\u2010stranded DNA, anticardiolipin and phosphatidylserine were assayed by ELISA. Lupus anticoagulants were also tested. Fifty\u2010seven per cent of the samples showed reactivity with at least one autoantigen. Such reactivities were more frequent among males than among females. Antiphospholipid autoantibodies were detected in 45% of our patients. The high rate of thrombosis associated with FD could be related, at least in part, to the presence of antiphospholipid autoantibodies in Fabry patients. We found the presence of ENAs, which are a characteristic finding of rheumatological diseases, previous a frequent misdiagnosis of FD, in around 39% of the cases. The detection of a high level of autoantibodies must be correlated clinically to determine the existence of an underlying autoimmune disease. With the recent development of therapy, the life expectancy in FD will increase and autoimmune diseases might play an important role in the morbidity of FD.<\/jats:p>","DOI":"10.1007\/s10545-007-0513-2","type":"journal-article","created":{"date-parts":[[2007,4,25]],"date-time":"2007-04-25T05:08:19Z","timestamp":1177477699000},"page":"365-369","source":"Crossref","is-referenced-by-count":43,"title":["High incidence of autoantibodies in Fabry disease patients"],"prefix":"10.1002","volume":"30","author":[{"given":"P.","family":"Martinez","sequence":"first","affiliation":[{"name":"Servicio de Hematolog\u00eda Hospital Penna Bah\u00eda Blanca Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aggio","sequence":"additional","affiliation":[{"name":"Servicio de Hematolog\u00eda Hospital Penna Bah\u00eda Blanca Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rozenfeld","sequence":"additional","affiliation":[{"name":"LISIN, Facultad de Ciencias Exactas Universidad Nacional de La Plata Calle 47 y 115 (1900) La Plata Pcia de Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,24]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"28","article-title":"Fabry's disease associated with rheumatoid arthritis. Multisystemic crossroads","volume":"20","author":"Arias Martinez N","year":"2003","journal-title":"An Med Interna"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(94)90173-2"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196705252762101"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1985.tb02269.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01540898"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600565453"},{"key":"e_1_2_1_8_1","first-page":"2741","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Desnick RJ","year":"1995"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000043901.45141.D4"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840715)54:2<312::AID-CNCR2820540222>3.0.CO;2-I"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(78)90130-X"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.167.3922.1268"},{"key":"e_1_2_1_13_1","first-page":"156","article-title":"The connective tissue diseases and the overall influence of gender","volume":"41","author":"Lahita RG","year":"1996","journal-title":"Int J Fertil Menopausal Stud"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1017\/S000156600000297X"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1982.tb02120.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290403"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.750"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.249"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2004.01309.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214530"},{"key":"e_1_2_1_21_1","first-page":"475","article-title":"Coexistence of Fabry's disease and systemic lupus erythematosus","volume":"16","author":"Rahman P","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000183006"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390626"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02755.x"},{"key":"e_1_2_1_25_1","first-page":"1849","article-title":"Clinical utility and specificity of anticardiolipin antibodies","volume":"18","author":"Soloninka CA","year":"1991","journal-title":"J Rheumatol"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.36.327"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012993305223"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0176-5"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419639"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199910)42:10<2132::AID-ANR13>3.0.CO;2-B"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-007-0513-2","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1007\/s10545-007-0513-2","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-007-0513-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:40:29Z","timestamp":1694738429000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-007-0513-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,24]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1007\/s10545-007-0513-2"],"URL":"https:\/\/doi.org\/10.1007\/s10545-007-0513-2","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,24]]}}}